In the present study, we further demonstrate that 13R,20-diHDHA has potential anti-inflammatory effects and can inhibit breast cancer stemness by inducing ROS production to alter Stat3/IL-6 signaling, and thus may be a promising potential therapeutic agent acting against breast CSCs. The gene discussed is IL6; the disease is breast cancer.